04 March 2008
Chief Medical Officer Appointed
Cambridge, UK – 4th March 2008: Acacia Pharma Ltd (Acacia) announces today that it has appointed Dr Gabriel Fox as its Chief Medical Officer.
Gabriel joins Acacia from the pharmaceutical company Hoffmann-La Roche, where he was most recently Head, Global Oncology Marketing and previously held a number of global development and medical marketing roles within the oncology franchise. Previously he worked as Medical Director for NeXstar Pharmaceuticals and Gilead Sciences Ltd and as a consultant for a number of companies, including both big pharma and small biotech ventures.
Gabriel studied medicine at the University of Cambridge and completed his clinical training at Addenbrooke’s Hospital. He also holds a Diploma in Marketing from the Chartered Institute of Marketing.
Dr Julian Gilbert, CEO of Acacia, commented, “Acacia Pharma is delighted that Gabriel has joined its management team. He brings in-depth knowledge of the oncology arena and has a unique mix of developmental and commercial experience from both small companies and large multinational organisations. We wish him every success.”
Dr Gabriel Fox added, “Acacia Pharma offers an outstanding opportunity to develop important treatments in high medical need areas such as cancer supportive care and peri-operative care, while building a new company from the foundations up. I am excited to be joining the excellent Acacia team in this formative stage.”